T. Rowe Price Associates’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27M Buy
361,442
+4,260
+1% +$318K ﹤0.01% 893
2025
Q1
$22.7M Buy
357,182
+2,901
+0.8% +$184K ﹤0.01% 927
2024
Q4
$27.7M Buy
354,281
+25,617
+8% +$2M ﹤0.01% 908
2024
Q3
$26.4M Sell
328,664
-19,397
-6% -$1.56M ﹤0.01% 932
2024
Q2
$28.8M Sell
348,061
-214,393
-38% -$17.7M ﹤0.01% 862
2024
Q1
$48M Buy
562,454
+156,665
+39% +$13.4M 0.01% 735
2023
Q4
$34.7M Sell
405,789
-114,335
-22% -$9.78M ﹤0.01% 800
2023
Q3
$46.6M Sell
520,124
-1,365
-0.3% -$122K 0.01% 703
2023
Q2
$44.4M Buy
521,489
+35,733
+7% +$3.04M 0.01% 734
2023
Q1
$40.2M Buy
485,756
+251
+0.1% +$20.8K 0.01% 742
2022
Q4
$38.2M Buy
485,505
+79,532
+20% +$6.26M 0.01% 734
2022
Q3
$30.1M Buy
405,973
+88,354
+28% +$6.54M ﹤0.01% 784
2022
Q2
$20.7M Buy
317,619
+33,266
+12% +$2.17M ﹤0.01% 1156
2022
Q1
$18M Sell
284,353
-40,007
-12% -$2.53M ﹤0.01% 1251
2021
Q4
$17.2M Sell
324,360
-26,905
-8% -$1.43M ﹤0.01% 1317
2021
Q3
$24.8M Sell
351,265
-205,049
-37% -$14.5M ﹤0.01% 1244
2021
Q2
$37.1M Buy
556,314
+4,242
+0.8% +$283K ﹤0.01% 1131
2021
Q1
$61.3M Sell
552,072
-55,960
-9% -$6.21M 0.01% 927
2020
Q4
$72.2M Sell
608,032
-5,130
-0.8% -$609K 0.01% 833
2020
Q3
$53.5M Sell
613,162
-10,811
-2% -$943K 0.01% 845
2020
Q2
$55.9M Sell
623,973
-5,428
-0.9% -$486K 0.01% 814
2020
Q1
$62.7M Buy
629,401
+3,491
+0.6% +$348K 0.01% 706
2019
Q4
$71.9M Sell
625,910
-791
-0.1% -$90.9K 0.01% 778
2019
Q3
$79.1M Buy
626,701
+23,178
+4% +$2.92M 0.01% 697
2019
Q2
$72.6M Buy
603,523
+96,335
+19% +$11.6M 0.01% 750
2019
Q1
$44.4M Sell
507,188
-51,445
-9% -$4.5M 0.01% 917
2018
Q4
$55.9M Sell
558,633
-267,877
-32% -$26.8M 0.01% 783
2018
Q3
$94.7M Buy
826,510
+267,321
+48% +$30.6M 0.01% 689
2018
Q2
$50.1M Sell
559,189
-333,546
-37% -$29.9M 0.01% 896
2018
Q1
$65.3M Sell
892,735
-631,487
-41% -$46.2M 0.01% 779
2017
Q4
$88.5M Sell
1,524,222
-1,080,040
-41% -$62.7M 0.01% 684
2017
Q3
$117M Sell
2,604,262
-625,424
-19% -$28.1M 0.02% 585
2017
Q2
$128M Sell
3,229,686
-241,205
-7% -$9.53M 0.02% 533
2017
Q1
$141M Sell
3,470,891
-1,931,040
-36% -$78.3M 0.03% 506
2016
Q4
$217M Sell
5,401,931
-102,592
-2% -$4.12M 0.04% 408
2016
Q3
$199M Buy
5,504,523
+133,393
+2% +$4.83M 0.04% 425
2016
Q2
$156M Buy
5,371,130
+708,620
+15% +$20.5M 0.03% 461
2016
Q1
$163M Buy
4,662,510
+1,988,730
+74% +$69.6M 0.03% 440
2015
Q4
$86.2M Buy
2,673,780
+822,653
+44% +$26.5M 0.02% 595
2015
Q3
$59.8M Buy
1,851,127
+51,927
+3% +$1.68M 0.01% 717
2015
Q2
$74.4M Buy
1,799,200
+507,920
+39% +$21M 0.02% 696
2015
Q1
$58M Buy
1,291,280
+6,200
+0.5% +$279K 0.01% 788
2014
Q4
$48.1M Buy
1,285,080
+269,900
+27% +$10.1M 0.01% 851
2014
Q3
$35.5M Buy
1,015,180
+999,000
+6,174% +$34.9M 0.01% 943
2014
Q2
$571K Sell
16,180
-2,600
-14% -$91.8K ﹤0.01% 1888
2014
Q1
$612K Hold
18,780
﹤0.01% 1844
2013
Q4
$791K Buy
18,780
+3,700
+25% +$156K ﹤0.01% 1738
2013
Q3
$601K Hold
15,080
﹤0.01% 1826
2013
Q2
$624K Buy
+15,080
New +$624K ﹤0.01% 1788